With Previously Treated News Today : Breaking News, Live Updates & Top Stories | Vimarsana

16.10.2023 - BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced the presentation of promising new data showcasing BeiGene’s robust, science-driven solid tumor portfolio of commercialized and pipeline medicines . Seite 1

Mark lanasaPresentations of companyEuropean unionDrug administrationChief medical officerSolid tumorsBiologics license applicationPlus chemoAdvanced gastricGastroesophageal junction adenocarcinomaFinal analysisNeoadjuvant tislelizumabPlus platinum doubletResectable stageMetastatic esophageal squamous cell carcinomaWith previously treated